Abstract
Rational structure-based drug design has been applied to the antibiotic thiostrepton, in an attempt to overcome some of its' limitations. The identification of a proposed binding fragment allowed construction of a number of key fragments, which were derivatised to generate a library of potential antibiotics. These were then evaluated to determine their ability to bind to the L11 binding domain of the prokaryotic ribosome and inhibit bacterial protein translation.
Original language | English |
---|---|
Pages (from-to) | 2455-8 |
Number of pages | 4 |
Journal | Bioorg. Med. Chem. Lett. |
Volume | 13 |
Issue number | 15 |
Publication status | Published - 4 Aug 2003 |
Keywords
- Anti-Bacterial Agents
- Bacteria
- Drug Design
- Escherichia coli
- Indicators and Reagents
- Methylation
- Microbial Sensitivity Tests
- Protein Biosynthesis
- RNA, Ribosomal
- Ribosomes
- Structure-Activity Relationship
- Thiostrepton